IL110006A - Pharmaceutical compositions with sensoric block and minimal motor blockade comprising ropivacaine salts - Google Patents

Pharmaceutical compositions with sensoric block and minimal motor blockade comprising ropivacaine salts

Info

Publication number
IL110006A
IL110006A IL11000694A IL11000694A IL110006A IL 110006 A IL110006 A IL 110006A IL 11000694 A IL11000694 A IL 11000694A IL 11000694 A IL11000694 A IL 11000694A IL 110006 A IL110006 A IL 110006A
Authority
IL
Israel
Prior art keywords
ropivacaine
use according
weight
block
medicament
Prior art date
Application number
IL11000694A
Other languages
English (en)
Other versions
IL110006A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL110006(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL110006A0 publication Critical patent/IL110006A0/xx
Publication of IL110006A publication Critical patent/IL110006A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Medicinal Preparation (AREA)
  • Air Conditioning Control Device (AREA)
  • Particle Accelerators (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
IL11000694A 1993-06-28 1994-06-13 Pharmaceutical compositions with sensoric block and minimal motor blockade comprising ropivacaine salts IL110006A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (2)

Publication Number Publication Date
IL110006A0 IL110006A0 (en) 1994-11-11
IL110006A true IL110006A (en) 1999-01-26

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11000694A IL110006A (en) 1993-06-28 1994-06-13 Pharmaceutical compositions with sensoric block and minimal motor blockade comprising ropivacaine salts

Country Status (32)

Country Link
US (2) US5670524A (cs)
EP (1) EP0706395B1 (cs)
JP (1) JP3725541B2 (cs)
CN (1) CN1074918C (cs)
AT (1) ATE216237T1 (cs)
BR (1) BR9406865A (cs)
CA (1) CA2165446C (cs)
CZ (1) CZ283300B6 (cs)
DE (2) DE69430427T2 (cs)
DK (1) DK0706395T3 (cs)
EE (1) EE03205B1 (cs)
ES (1) ES2099048T3 (cs)
FI (1) FI956269A7 (cs)
GR (1) GR970300013T1 (cs)
HU (1) HU218949B (cs)
IL (1) IL110006A (cs)
IS (1) IS4174A (cs)
LT (1) LT3449B (cs)
LV (1) LV12918B (cs)
MY (1) MY119360A (cs)
NO (1) NO955313L (cs)
NZ (1) NZ268110A (cs)
PH (1) PH31258A (cs)
PL (1) PL175518B1 (cs)
PT (1) PT706395E (cs)
RU (1) RU2152215C1 (cs)
SA (1) SA94150010B1 (cs)
SE (1) SE9302218D0 (cs)
SG (1) SG49078A1 (cs)
SK (1) SK280111B6 (cs)
TW (1) TW285640B (cs)
WO (1) WO1995000148A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
AU742488B2 (en) * 1997-07-21 2002-01-03 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US9849088B2 (en) 2012-05-10 2017-12-26 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
SG11201407323WA (en) * 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of local pain
JP6114841B2 (ja) 2013-02-28 2017-04-12 ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． グリコピロレート塩
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE40994T1 (de) * 1983-08-01 1989-03-15 Astra Laekemedel Ab L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung.
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
BR9406865A (pt) 1996-03-26
SE9302218D0 (sv) 1993-06-28
ATE216237T1 (de) 2002-05-15
DK0706395T3 (da) 2002-07-22
ES2099048T3 (es) 2002-11-16
CZ283300B6 (cs) 1998-02-18
EE03205B1 (et) 1999-08-16
US5834489A (en) 1998-11-10
LT3449B (en) 1995-10-25
US5670524A (en) 1997-09-23
HU9503692D0 (en) 1996-02-28
HU218949B (hu) 2001-01-29
SA94150010B1 (ar) 2006-04-04
DE69430427D1 (de) 2002-05-23
SG49078A1 (en) 1998-05-18
AU692161B2 (en) 1998-06-04
PL175518B1 (pl) 1999-01-29
MY119360A (en) 2005-05-31
EP0706395A1 (en) 1996-04-17
SK280111B6 (sk) 1999-08-06
LTIP1958A (en) 1995-01-31
NO955313D0 (no) 1995-12-27
SK164695A3 (en) 1996-07-03
GR970300013T1 (en) 1997-05-31
PH31258A (en) 1998-06-18
DE706395T1 (de) 1997-09-04
NZ268110A (en) 1999-06-29
WO1995000148A1 (en) 1995-01-05
PT706395E (pt) 2002-09-30
FI956269A0 (fi) 1995-12-27
FI956269L (fi) 1995-12-27
CA2165446C (en) 2005-07-05
PL312198A1 (en) 1996-04-01
JP3725541B2 (ja) 2005-12-14
CN1074918C (zh) 2001-11-21
LV12918B (en) 2003-03-20
EP0706395B1 (en) 2002-04-17
RU2152215C1 (ru) 2000-07-10
DE69430427T2 (de) 2002-11-14
CA2165446A1 (en) 1995-01-05
HUT75115A (en) 1997-04-28
HK1010344A1 (en) 1999-06-17
FI956269A7 (fi) 1995-12-27
CN1126435A (zh) 1996-07-10
CZ336495A3 (en) 1996-06-12
AU7086694A (en) 1995-01-17
NO955313L (no) 1995-12-27
IL110006A0 (en) 1994-11-11
TW285640B (cs) 1996-09-11
IS4174A (is) 1994-12-29
JPH09500620A (ja) 1997-01-21
ES2099048T1 (es) 1997-05-16

Similar Documents

Publication Publication Date Title
Stenseth et al. Epidural morphine for postoperative pain: experience with 1085 patients
Lehmann Tramadol for the management of acute pain
Wasylak et al. Reduction of post-operative morbidity following patient-controlled morphine
JPH09503777A (ja) 慢性痛の処置に有用なレボブピバカイン
JPH09503778A (ja) 鎮痛剤およびその使用
KR101437461B1 (ko) 부프레노르핀 및 날메펜을 함유하는 개량 약용 조성물
CA2165446C (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
US5187177A (en) Method and a pharmaceutical preparation for treating pain
JP2620642B2 (ja) 麻薬性鎮痛剤とベンゾジアゼピンとを組み合わせて非経口投与した後に観察される平均血圧の低下を拮抗させるための医薬品
Banerjee et al. A comparative study between epidural butorphanol, nalbuphine, and fentanyl for post-operative analgesia in lower abdominal surgeries
AU692161C (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
Milligan et al. The characteristics of analgesic requirements following subarachnoid diamorphine in patients undergoing total hip replacement
Stanton-Hicks et al. High thoracic epidural with sufentanil for post-thoracotomy pain
RU2240144C1 (ru) Способ анестезии при онкохирургических операциях на органах брюшной полости
HK1010344B (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
RU2016586C1 (ru) Способ общего обезболивания
Siler et al. Lidocaine hydrochloride versus lidocaine bicarbonate for epidural anesthesia in outpatients undergoing arthroscopic surgery
Corssen Proper Use of Ketamine and Innovar
AU7231291A (en) Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
SWARTZ Narcan (Naloxone HCI)
IE911793A1 (en) Use of local anaesthetic agents in the manufacture of¹pharmaceutical preparations for iontophoresis
EA017624B1 (ru) Способ общего обезболивания

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees